University of Edinburgh
Modulation of neutrophilic inflammation in rheumatoid arthritis by autoantibody glycosylation
Abstract
dc:description.abstractRheumatoid arthritis (RA) is a chronic autoimmune disease primarily affecting the synovial joints. During RA development and progression, single N-linked glycans present on IgG Fc chains undergo dynamic changes. This includes the increased abundance of agalactosylated Fc N-glycans that are assumed to be pro-inflammatory. Neutrophilic inflammation is a major contributor to RA pathogenesis. RA is characterised by the presence of abundant autoantibodies that form immune complexes (ICs) which precipitate onto synovial joint surfaces. Neutrophils interact with ICs via cell surface Fc𝛾 receptors, resulting in localised inflammation. However, the relevance of antibody glycosylation to neutrophil-mediated responses remain unknown. This project engineered recombinant human IgG1 and IgG4 antibodies that carried N-glycans associated with health (galactosylated) or disease (agalactosylated) using glycoengineered Chinese Hamster Ovary cells. These Fc N-glycan profiles were selected based on an extensive review that compared IgG glycosylation patterns in various autoimmune diseases including RA, Systematic Lupus Erythematosus (SLE), Multiple Scelorsis (MS), Type 1 Diabetes (T1D), Primary Biliary Cholangitis (PBC), Crohn’s Disease (CD) and Ulcerative Colitis (UC). Glycoengineered antibodies were used to generate immobilised ICs to investigate their ability to induce functional responses in neutrophils isolated from healthy donor and RA patient blood. Disease and health-associated IgG glycosylation patterns differed by the absence of galactose and sialic acid in most autoimmune diseases, with the exception of T1D, where the opposite was true. Unexpectedly, neutrophils stimulated by immobilised ICs made up of agalactosylated IgG adhered less and produced less reactive oxygen species (ROS) compared to their galactosylated counterparts. These responses were consistent in neutrophils derived from healthy donors and RA patients. Fc𝛾RIIA was required for ROS production by neutrophils plated onto immobilised ICs, and mechanistic studies revealed reduced binding of galactosylated IgG to multiple neutrophil Fc𝛾Rs. Consequently, galactosylated IgG were able to activate p38 MAPK and Akt more strongly than agalactosylated IgG. ROS production by neutrophils stimulated with immobilised ICs was dependent upon MAPK and PI3K, providing a mechanistic explanation for the observed neutrophil responses to altered IgG glycosylation. This project demonstrated that agalactosylated IgG do not exhibit pro-inflammatory properties, contrary to common assumptions. Whether this holds true also in immune cells other than neutrophils remains to be determined. However, it raises the question of whether changes in IgG glycosylation profiles might in fact represent a protective response to excessive inflammation.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Pumpe, Caroline Elisabeth
- Advisors dc:contributor.advisor
-
- Vermeren, Sonja
- Benezech, Cecile
- Hayward, Caroline
- Gray, Mohini
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7842